Back to Search
Start Over
The interferon story continues: EORTC CLTG study explores pegylated interferon α-2a's role in treating mycosis fungoides/Sézary syndrome.
- Source :
-
The British journal of dermatology [Br J Dermatol] 2024 Aug 14; Vol. 191 (3), pp. 321-322. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Conflicts of interest R.S. has received honoraria from 4SCAG, Stemline, Recordati and Kyowa Kirin as a consultant.
- Subjects :
- Humans
Treatment Outcome
Antineoplastic Agents therapeutic use
Interferon-alpha therapeutic use
Mycosis Fungoides drug therapy
Polyethylene Glycols therapeutic use
Polyethylene Glycols administration & dosage
Skin Neoplasms drug therapy
Sezary Syndrome drug therapy
Recombinant Proteins administration & dosage
Recombinant Proteins therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2133
- Volume :
- 191
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The British journal of dermatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38703059
- Full Text :
- https://doi.org/10.1093/bjd/ljae188